Patient
SITE003-0154
enrolled Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE003 (CAN) (Dr. Okafor)
consented 2026-03-09
Adverse events
2
Serious AEs
0
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 2
mild
assessed
2026-07-27
Grade 1 Nausea — outcome: RECOVERED/RESOLVED; onset 2023-01-20 (study day 131); relationship: not assessed
mild
assessed
2026-05-14
Grade 1 Pruritus — outcome: RECOVERED/RESOLVED; onset 2022-11-07 (study day 57); relationship: RELATED
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.